NMT1 and ovarian carcinoma: Ovarian cancer metastases have higher NMT1 protein levels than paired ovarian primary cancers, and aggressive ovarian cancers have higher levels of Src, suggesting a possible mechanism for zelenirstat activity in this disease [14].